Future is in doubt for cheaper versions of biologic drugs
TRENTON, N.J. (AP) — They were the drugs that were supposed to save the U.S. tens of billions of dollars.
Called "biosimilars," they are near-copies of complex and expensive biologic drugs...
Former No. 1 Wozniacki has rheumatoid arthritis
SINGAPORE (AP) — Caroline Wozniacki was diagnosed with rheumatoid arthritis before the U.S. Open, the Danish tennis player revealed at the WTA Finals on Thursday.
She made the announcement after being eliminated from the year-end competition following a 5-7, 7-5, 6-3 loss to Elina Svitolina in her third round-robin match.
Q: My brother died from Wegener’s disease at age 62. Could you please tell me more about this disease — what causes it and what can be done? Could there be a connection to the fact that our father died of rheumatoid arthritis at age 64?
Dear Doctor: My brother died from Wegener's disease at age 62. Could you please tell me more about this disease -- what causes it and what can be done? Could there be a connection to the fact that our father died of rheumatoid arthritis at age 64?
Mainer calls for affordable rheumatoid arthritis treatment
PORTLAND, Maine (AP) — A Maine woman who suffers from rheumatoid arthritis has told a senate committee that the high cost of treating the disease is an unfair burden on thousands of patients.
Lilly lays out faster time frame for FDA drug resubmission
INDIANAPOLIS (AP) — Eli Lilly says it will resubmit its potential rheumatoid arthritis treatment to regulators several months faster than expected.
The drugmaker said Wednesday that it will give baricitinib back to the Food and Drug Administration for review by the end of January, and the agency will not require a new clinical study.
FDA approves 2nd near-copy of Remicade for immune disorders
Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.
The U.S. Food and Drug Administration approved Renflexis, developed by Samsung Bioepis Co. of South Korea. Its U.S. partner, Merck & Co. of Kenilworth, New Jersey, will market Renflexis.
FDA approves near-copy of Remicade for immune disorders
Federal regulators have approved an alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.
The Food and Drug Administration said Friday that it approved Renflexis, developed by Samsung Bioepis Co. of South Korea. It will be marketed by its U.S. partner, Merck & Co. of Kenilworth, New Jersey.
Lilly’s rheumatoid arthritis pill rejected by regulators
Eli Lilly said U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November.
The Food and Drug Administration said in a letter to the company that it needed more information about the drug's safety and the best doses, Lilly said Friday in a statement.
Having Rheumatoid Arthritis May Increase Heart Risk
TUESDAY, Nov. 15, 2016 (HealthDay News) -- People with rheumatoid arthritis may have an increased risk for a heart attack, stroke and other heart disease-related problems, a new study suggests.
Researchers examined data from 353 rheumatoid arthritis patients in the Netherlands who were followed for up to 15 years.
FDA approves lower-cost alternative to biotech drug Humira
WASHINGTON (AP) — Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.
The Food and Drug Administration cleared a near-copy of the drug, dubbed Amjevita, developed by Amgen Inc. Regulators approved the drug for more than a half-dozen conditions listed on the original drug's label, including severe psoriasis and Crohn's diseases.
Patent for J&J’s Remicade invalidated, cheaper version looms
TRENTON, N.J. (AP) — A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent on the drug is invalid.
Doc: RA meds best used under rheumatologist’s care
Dear Dr. Roach: I am 69 years old and being treated for rheumatoid arthritis with weekly self-injections of methotrexate. Should I expect these injections to reduce or minimize the pain in my hands, fingers and shoulders? There seem to be constant flare-ups in my fingers. In fact, I am seeing a hand specialist in a couple of weeks for what I suspect is trigger finger in two fingers on my dominant hand. I like to play golf; I am in good health, but it may be that RA takes me away...
Lower-cost biotech drug gets thumbs up from FDA panel
WASHINGTON (AP) — The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory diseases.
A panel of Food and Drug Administration advisers voted unanimously in favor of Amgen's version of AbbVie's Humira, a biotech drug that raked in nearly $15 billion last year, according to IMS Health. While not binding,...
- Business WireGilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid ArthritisOctober 10, 2019
- Business Wire CreakyJoints Contributes to National Committee for Quality Assurance’s (NCQA) Value-Based Care Model Amplifying Patients’ Voices in Treatment DecisionsAugust 21, 2019
- Business WireGlobal Autoinjectors Market Set to Grow by 22.5% Over 2019-2025 - ResearchAndMarkets.comAugust 12, 2019
- Business WireGlobal Rheumatoid Arthritis Diagnostic Devices Market 2019-2023 | 6% CAGR Projection Over the Next Five Years | TechnavioJuly 26, 2019
- Business WireGilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)May 29, 2019
- Columbus Telegram4 signs & symptoms which may mean your rheumatoid arthritis is uncontrolledMay 18, 2019
- Columbus TelegramTips that may help manage life with a chronic illnessMarch 25, 2019
- Norfolk Daily NewsCut The StressJune 26, 2018
- Columbus TelegramReaching your personal goals with a chronic illnessJune 12, 2018